GlassScriptPhysician profile
Farbod Esmailian
NPI 1578677969
$7,721.07
in general payments reported to CMS, 2019-2025
17 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,670 · 2020: $439 · 2021: $1,175 · 2022: $1,266 · 2023: $539 · 2024: $1,233 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,312 · Debt Forgiveness: $859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,312.11 |
| Debt Forgiveness | $859.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,160.47 | 2019-2022 | |
| Sientra, INC. | $961.55 | 2019-2022 | |
| Johnson & Johnson Health Care Systems INC. | $859.25 | 2024 | |
| Abbvie INC. | $788.66 | 2023-2025 | |
| Mentor Worldwide LLC | $640.65 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Memorygel Breast Implant, Mentor Cpx 2 Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $472.17 | 2019-2025 | |
| Tela Bio, INC. | $231.14 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Becton, Dickinson and Company | $142.85 | 2022 | |
| Ethicon US, LLC | $101.10 | 2021-2023 | Dermabond Prineo, Stratafix |
| Integra Lifesciences Corporation | $93.21 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Davol INC. | $67.68 | 2022 | |
| Galderma Laboratories, L.P. | $56.73 | 2021-2023 | |
| Kerecis Limited | $40.06 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Motiva USA, LLC | $32.64 | 2025 | |
| Tepha INC | $28.04 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $26.62 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $18.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farbod Esmailian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.